Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
04/2007
04/26/2007WO2007047306A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
04/26/2007WO2007047305A1 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
04/26/2007WO2007046721A2 A method of manufacturing 3-(4-hydroxyphenyl)propanoic acid amide, its application in the manufacture of anti-aging compositions and an anti-aging composition
04/26/2007WO2007045573A1 Phenyl-acetamide nnrt inhibitors
04/26/2007WO2007045386A1 Compounds and relative use for the control of phytopathogens
04/26/2007WO2007019503A3 Management of ophthalmologic disorders, including macular degeneration
04/26/2007WO2007014839A3 Cathepsin k inhibitors
04/26/2007WO2005112921A3 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
04/26/2007US20070093487 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
04/26/2007US20070092467 Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers
04/26/2007CA2625047A1 Phenyl-acetamide nnrt inhibitors
04/26/2007CA2624904A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
04/25/2007EP1777246A2 Polymers containing amide groups for controlling rheology
04/25/2007EP1776351A1 Uv filter
04/25/2007EP1776011A1 Fungicidal composition containing acid amide derivative
04/25/2007EP1047645B8 Compound for use as a mineral fibre binder and process for providing such
04/25/2007CN1951908A Preparation process for synthesizing AGA using loop reactor
04/25/2007CN1951899A Aspirin-triggered lipid mediators
04/25/2007CN1312120C Adamantane derivatives
04/25/2007CN1312119C Process for synthesizing aryl substituted N-aryl amide compounds
04/24/2007US7208631 2-alkylcysteinamide or salt thereof, process for producing these, and use of these
04/24/2007US7208630 Having a chimeric structure based, in part, on two naturally occurring Hsp90 inhibitors: radicicol ("RDC") and geldanamycin ("GDA").
04/24/2007US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2007US7208622 Methods for producing nateglinide crystals
04/24/2007US7208601 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants
04/24/2007US7208527 Potassium channel modulators
04/24/2007CA2403902C Malonamic acids and derivatives thereof as thyroid receptor ligands
04/24/2007CA2289472C Excitatory amino acid receptor modulators
04/19/2007WO2007043466A1 Process for producing amide compound
04/19/2007WO2007042114A1 Process for the oxidation of organic substrates by means of singlet oxygen at high reaction temperatures
04/19/2007WO2007000339A8 Bicyclic derivatives as p38 kinase inhibitors
04/19/2007WO2007000337A8 Bicyclic derivatives as p38 kinase inhibitors
04/19/2007WO2006102243A3 Alpha ketoamide compounds as cysteine protease inhibitors
04/19/2007US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
04/19/2007CA2623759A1 Pyridopyrimidinone inhibitors of pim 1 and/or pim-3
04/18/2007EP1774011A1 Process for preparing monomers and polymers thereof
04/18/2007EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
04/18/2007EP1773780A2 Amido compounds and their use as pharmaceuticals
04/18/2007EP1773758A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors
04/18/2007EP1773756A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
04/18/2007EP1773755A1 Process for the production of polyisocyanates
04/18/2007EP1453792B1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007EP1028940B1 Process to produce oxazolidinones
04/18/2007CN1950385A Ferrocenyl ligands for homogeneous, enantioselective hydrogenation catalysts
04/18/2007CN1950332A Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues
04/18/2007CN1950331A Polymorphic forms of nateglinide
04/18/2007CN1310940C Process for producing triterpene derivative
04/18/2007CN1310881C New 3-aryl-2-hydroxypropionic acid derivative I
04/17/2007US7205438 Solvent recovery blends from diene production
04/17/2007US7205437 For contraception, treatment of hormone-related (aging) conditions, and sexual dysfunction
04/17/2007US7205436 Process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines
04/17/2007US7205435 Type B botulism toxin inhibitors
04/17/2007US7205331 Pyrrole derivatives, for controlling plant diseases caused by fungal plant pathogens
04/17/2007US7205290 Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use
04/17/2007CA2318381C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
04/17/2007CA2269589C A solid-phase technology for the preparation of amides
04/17/2007CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof
04/12/2007WO2007041307A1 Puleganic amides as insect repellants
04/12/2007WO2007040516A1 Novel cyclohexene carboamides and carbothioamides
04/12/2007WO2007039034A1 Process for preparing n-acetylaminoacetophenones and downstream products
04/12/2007WO2007015002A3 Novel crystalline iv form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form
04/12/2007WO2006138512A3 Bis-aromatic amides and their uses as sweet flavor modifiers, tastants and taste enhancers
04/12/2007WO2006132662A3 Self assembled nanostructures and methods for preparing the same
04/12/2007US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases
04/12/2007US20070082907 Peroxisome proliferator activated receptor modulators
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/12/2007US20070082877 Difluoromethylbenzanilides and use thereof for combating micro-organisms, intermediate products and use thereof
04/12/2007CA2623428A1 Puleganic amides as insect repellants
04/11/2007EP1772453A1 Process to produce Oxazolidinones
04/11/2007EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives
04/11/2007EP1073623B1 Substituted amino acids as erythropoietin mimetics
04/11/2007EP0885180B1 Stabilized monomer composition
04/11/2007CN1946730A Cycloolefin phosphine ligands and their use in catalysis
04/11/2007CN1944406A Indole heterocyclic compounds and intermediate, and synthetic method
04/11/2007CN1943786A Ester compound and its medicinal application
04/11/2007CN1309709C C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
04/10/2007US7202404 Controlling plant fungi
04/10/2007US7202383 Compounds useful for modulating abnormal cell proliferation
04/10/2007US7202348 Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
04/10/2007US7202278 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; for treatment of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases
04/10/2007US7202275 Malonamic acids and derivatives thereof as thyroid receptor ligands
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007US7202227 Multifunctional molecular complexes for gene transfer to cells
04/10/2007US7201876 Ion-detecting sensors comprising plasticizer-free copolymers
04/10/2007CA2195346C Benzocyclobutenones and polymers derived therefrom
04/10/2007CA2133991C T-butyl cascade polymers
04/05/2007WO2007038116A1 Process to prepare amino acid derivatives
04/05/2007WO2007037812A1 Amide forming chemical ligation
04/05/2007WO2007015003A3 Novel crystalline iii form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form
04/05/2007US20070078246 Type II H-extraction; mercapto-functional benzophenone-type chromophore bound to butadiene/styrene rubber so it does not remain in final odorless product; UV radiation curable hot melt pressure sensitive adhesive; photocurable composition with multifunctional thiol crosslinker and a polyene; thiol-ene
04/05/2007US20070078189 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
04/05/2007US20070078184 Amino alcohol derivatives, medicinal composition containing the same, and use of these
04/05/2007US20070078169 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists
04/05/2007US20070078130 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases
04/04/2007EP1768954A2 2-methylpropanamides and their use as pharmaceuticals
04/04/2007EP1768952A2 Preparation of beta-amino acids having affinity for the alpha-2-delta protein
04/04/2007EP1691804B1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs
04/04/2007EP1615876B1 Method for the purification of dimethylacetamide (dmac)
04/04/2007EP1403238B1 Process for producing fluorinated alcohol
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 289